Importantly, treatment with a single dose of Gal-9 eliminated the CD34+ AML cells even after ‘long-term’ incubation of up to 7 days, whereas CB-derived CD34+ stem cells remained unaffected, as shown by microscopy images (Fig. 2H). The gene discussed is CD34; the disease is acute myeloid leukemia.